Spectra254, a developer of high-power, easy-to-use, affordable UVC light decontamination systems, announced that results from an independent laboratory study finds Spectra254’s 1000 Series ultraviolet light system to be 99.9 percent effective in killing an Ebola surrogate virus.
The study, released on Nov. 6 by Antimicrobial Test Laboratories, found the ultraviolet light system is 99.9 percent effective at killing the Ebola surrogate on surfaces at a distance of up to 10 feet. These results are significant given the Ebola virus’ recent infection rates worldwide.
The laboratory measured efficacy at distances of five, 10 and 15 feet, both vertically and horizontally. The study tested the microorganism Feline calicivirus (FCV), the closest to the real virus that can legally be tested. Feline calicivirus also meets the CDC Ebola Disinfection Guidelines for Selection of Appropriate Test Virus.
“The independent lab finding proving the effectiveness of Spectra254 system eliminating Ebola is substantial,” said Sanford Green, President of Spectra254. “Ebola is a virus that has ravaged West Africa and has the world on edge. Healthcare professionals need proven tools and equipment that can reliably eliminate this virus on surfaces.”
The Spectra 1000 Series UVC light decontamination systems use high-intensity UVC light to eliminate pathogens on surfaces. The company’s devices are currently in use at hospitals throughout North America, as well as ambulatory care, medical clinics and education facilities and soon to be Sierra Leone, where the World Health Organization has selected Spectra254 systems for use in hospitals and clinics.
Multiple analyses performed for Spectra254 in further independent scientific testing documented that UVC light from the Spectra Systems was also highly effective (greater than 99 percent) in killing MRSA and C. difficile spores on solid surfaces and in inhibiting the growth over a range of exposure times and distances.
Spectra254 has been identified as the company with a practical approach to UVC disinfection in healthcare and related markets, offering multiple systems that are independently tested, easy to use and offer an expanded set of features, functions and benefits normally reserved for systems at a much higher price. Spectra254 systems offer the lowest total cost of ownership. All third-party tests and reports are available by request or from the company’s website.
Spectra systems are manufactured and assembled in a U.S.-based ISO 9000 facility that meets or exceeds the quality assurance standards outlined by the International Organization of Standards. Full product line details are available at www.spectra254.com, by calling 203-796-5315 direct or through emailing firstname.lastname@example.org.